US Stock MarketDetailed Quotes

GRTX Galera Therapeutics

Watchlist
  • 0.120
  • -0.025-17.31%
15min DelayClose Jun 4 16:00 ET
  • 0.120
  • +0.000+0.08%
Post 16:00 ET
6.52MMarket Cap-131P/E (TTM)

Galera Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-67.03%4.58M
-8.35%46.95M
-60.74%5.18M
-14.44%11.09M
40.89%16.81M
5.53%13.88M
-30.18%51.23M
-9.06%13.19M
-36.17%12.96M
-43.43%11.93M
Selling and administrative expenses
-53.26%3.09M
12.97%22.84M
-60.43%1.99M
2.91%4.99M
74.68%9.25M
30.95%6.61M
-3.52%20.21M
-4.98%5.02M
-11.55%4.85M
3.34%5.29M
-General and administrative expense
-53.26%3.09M
12.97%22.84M
-60.43%1.99M
2.91%4.99M
74.68%9.25M
30.95%6.61M
-3.52%20.21M
-4.98%5.02M
-11.55%4.85M
3.34%5.29M
Research and development costs
-79.54%1.49M
-22.24%24.12M
-60.94%3.19M
-24.82%6.09M
13.94%7.56M
-10.30%7.27M
-40.84%31.01M
-11.40%8.16M
-45.28%8.11M
-58.44%6.64M
Operating profit
67.03%-4.58M
8.35%-46.95M
60.74%-5.18M
14.44%-11.09M
-40.89%-16.81M
-5.53%-13.88M
30.18%-51.23M
9.06%-13.19M
36.17%-12.96M
43.43%-11.93M
Net non-operating interest income expense
105.12%196K
11.26%-9.82M
86.66%-410K
45.48%-1.68M
-48.59%-3.91M
-67.23%-3.83M
-54.50%-11.07M
-33.19%-3.07M
-32.27%-3.07M
-102.78%-2.63M
Non-operating interest income
-50.38%196K
215.22%1.6M
18.00%295K
140.35%411K
595.77%494K
2,721.43%395K
1,481.25%506K
6,150.00%250K
5,600.00%171K
1,083.33%71K
Non-operating interest expense
--0
-1.36%11.41M
-78.79%705K
-35.69%2.09M
62.99%4.4M
83.37%4.22M
60.84%11.57M
43.77%3.32M
39.45%3.25M
107.30%2.7M
Other net income (expense)
-231,100.00%-2.31M
-200.00%-1K
-230,900.00%-2.31M
-1K
75.00%-1K
200.00%1K
50.00%-1K
50.00%-1K
Gain on sale of security
----
-200.00%-3K
-200.00%-1K
0.00%-1K
----
---1K
75.00%-1K
200.00%1K
50.00%-1K
50.00%-1K
Special income (charges)
----
---2.31M
--0
---2.31M
----
----
--0
--0
--0
----
-Less:Restructuring and merger&acquisition
----
--2.31M
--0
--2.31M
----
----
--0
--0
--0
----
Income before tax
75.26%-4.38M
5.15%-59.08M
65.64%-5.59M
5.99%-15.07M
-42.27%-20.71M
-14.68%-17.71M
22.65%-62.29M
3.27%-16.26M
29.14%-16.03M
34.97%-14.56M
Income tax
0
-70K
Net income
75.26%-4.38M
5.05%-59.08M
65.49%-5.59M
5.99%-15.07M
-42.27%-20.71M
-14.68%-17.71M
22.74%-62.22M
3.68%-16.19M
29.14%-16.03M
34.97%-14.56M
Net income continuous Operations
75.26%-4.38M
5.05%-59.08M
65.49%-5.59M
5.99%-15.07M
-42.27%-20.71M
-14.68%-17.71M
22.74%-62.22M
3.68%-16.19M
29.14%-16.03M
34.97%-14.56M
Minority interest income
Net income attributable to the parent company
75.26%-4.38M
5.05%-59.08M
65.49%-5.59M
5.99%-15.07M
-42.27%-20.71M
-14.68%-17.71M
22.74%-62.22M
3.68%-16.19M
29.14%-16.03M
34.97%-14.56M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
75.26%-4.38M
5.05%-59.08M
65.49%-5.59M
5.99%-15.07M
-42.27%-20.71M
-14.68%-17.71M
22.74%-62.22M
3.68%-16.19M
29.14%-16.03M
34.97%-14.56M
Basic earnings per share
84.00%-0.08
42.17%-1.33
94.83%-0.03
45.00%-0.33
11.11%-0.48
13.79%-0.5
26.28%-2.3
9.38%-0.58
30.23%-0.6
38.64%-0.54
Diluted earnings per share
84.00%-0.08
42.17%-1.33
94.83%-0.03
45.00%-0.33
11.11%-0.48
13.79%-0.5
26.28%-2.3
9.38%-0.58
30.23%-0.6
38.64%-0.54
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -67.03%4.58M-8.35%46.95M-60.74%5.18M-14.44%11.09M40.89%16.81M5.53%13.88M-30.18%51.23M-9.06%13.19M-36.17%12.96M-43.43%11.93M
Selling and administrative expenses -53.26%3.09M12.97%22.84M-60.43%1.99M2.91%4.99M74.68%9.25M30.95%6.61M-3.52%20.21M-4.98%5.02M-11.55%4.85M3.34%5.29M
-General and administrative expense -53.26%3.09M12.97%22.84M-60.43%1.99M2.91%4.99M74.68%9.25M30.95%6.61M-3.52%20.21M-4.98%5.02M-11.55%4.85M3.34%5.29M
Research and development costs -79.54%1.49M-22.24%24.12M-60.94%3.19M-24.82%6.09M13.94%7.56M-10.30%7.27M-40.84%31.01M-11.40%8.16M-45.28%8.11M-58.44%6.64M
Operating profit 67.03%-4.58M8.35%-46.95M60.74%-5.18M14.44%-11.09M-40.89%-16.81M-5.53%-13.88M30.18%-51.23M9.06%-13.19M36.17%-12.96M43.43%-11.93M
Net non-operating interest income expense 105.12%196K11.26%-9.82M86.66%-410K45.48%-1.68M-48.59%-3.91M-67.23%-3.83M-54.50%-11.07M-33.19%-3.07M-32.27%-3.07M-102.78%-2.63M
Non-operating interest income -50.38%196K215.22%1.6M18.00%295K140.35%411K595.77%494K2,721.43%395K1,481.25%506K6,150.00%250K5,600.00%171K1,083.33%71K
Non-operating interest expense --0-1.36%11.41M-78.79%705K-35.69%2.09M62.99%4.4M83.37%4.22M60.84%11.57M43.77%3.32M39.45%3.25M107.30%2.7M
Other net income (expense) -231,100.00%-2.31M-200.00%-1K-230,900.00%-2.31M-1K75.00%-1K200.00%1K50.00%-1K50.00%-1K
Gain on sale of security -----200.00%-3K-200.00%-1K0.00%-1K-------1K75.00%-1K200.00%1K50.00%-1K50.00%-1K
Special income (charges) -------2.31M--0---2.31M----------0--0--0----
-Less:Restructuring and merger&acquisition ------2.31M--0--2.31M----------0--0--0----
Income before tax 75.26%-4.38M5.15%-59.08M65.64%-5.59M5.99%-15.07M-42.27%-20.71M-14.68%-17.71M22.65%-62.29M3.27%-16.26M29.14%-16.03M34.97%-14.56M
Income tax 0-70K
Net income 75.26%-4.38M5.05%-59.08M65.49%-5.59M5.99%-15.07M-42.27%-20.71M-14.68%-17.71M22.74%-62.22M3.68%-16.19M29.14%-16.03M34.97%-14.56M
Net income continuous Operations 75.26%-4.38M5.05%-59.08M65.49%-5.59M5.99%-15.07M-42.27%-20.71M-14.68%-17.71M22.74%-62.22M3.68%-16.19M29.14%-16.03M34.97%-14.56M
Minority interest income
Net income attributable to the parent company 75.26%-4.38M5.05%-59.08M65.49%-5.59M5.99%-15.07M-42.27%-20.71M-14.68%-17.71M22.74%-62.22M3.68%-16.19M29.14%-16.03M34.97%-14.56M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 75.26%-4.38M5.05%-59.08M65.49%-5.59M5.99%-15.07M-42.27%-20.71M-14.68%-17.71M22.74%-62.22M3.68%-16.19M29.14%-16.03M34.97%-14.56M
Basic earnings per share 84.00%-0.0842.17%-1.3394.83%-0.0345.00%-0.3311.11%-0.4813.79%-0.526.28%-2.39.38%-0.5830.23%-0.638.64%-0.54
Diluted earnings per share 84.00%-0.0842.17%-1.3394.83%-0.0345.00%-0.3311.11%-0.4813.79%-0.526.28%-2.39.38%-0.5830.23%-0.638.64%-0.54
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg